Table 1.
All patients | Group A | Group B | p | |
---|---|---|---|---|
(N = 31) n(%) | (n = 17) n(%) | (n = 14) n(%) | ||
Gender | ||||
Male | 10(32.3) | 6(35.3) | 4(28.6) | 0.9901,2 |
Female | 21(67.7) | 11(64.7) | 10(71.4) | |
Mean age (years) | 61.32 | 59.71 | 63.29 | 0.3403 |
SD | 17.14 | 17.33 | 17.34 | |
Range | 19–86 | 19–86 | 27–80 | |
School education | ||||
Compulsory | 5(16.1) | 1(5.9) | 4(28.6) | |
Post-compulsory | 18(58.1) | 12(70.6) | 6(42.9) | 0.1701 |
College | 8(25.8) | 4(23.5) | 4(28.6) | |
Relationship | ||||
Partnership | 24(77.4) | 12(70.6) | 12(85.7) | 0.5681,2 |
Single | 7(22.6) | 5(29.4) | 2(14.3) | |
Children | ||||
Yes | 22(71.0) | 11(64.7) | 11(78.6) | 0.6541,2 |
No | 9(29.0) | 6(35.3) | 3(21.4) | |
Epilepsy | ||||
Yes | 7(22.6) | 1(5.9) | 6(42.9) | 0.044 1 , 2 |
No | 24(77.4) | 16(94.1) | 8(57.1) | |
Diagnoses | ||||
Vestibular schwannoma WHO I | 1 | |||
Well-differentiated chondrosarcoma (G1, focal G2) | 1 | |||
Pituitary adenoma | 5 | |||
Meningioma WHO I-II | 10 | |||
Anaplastic oligodendroglioma WHO III | 2 | |||
Anaplastic astrocytoma WHO III | 1 | |||
Glioblastoma WHO IV | 7 | |||
Hemangiopericytoma WHO III | 1 | |||
Metastases | 3 |
Group A, benign tumours; Group B, malignant tumours; and SD, standard deviation.
Frequency differences were tested with Chi-squared test;
Yates continuity correction was used; and
Mean differences were tested with Mann-Whitney U-test.